These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 18448571)

  • 1. The macrolide everolimus forms an unusual metabolite in animals and humans: identification of a phosphocholine ester.
    Zollinger M; Sayer C; Dannecker R; Schuler W; Sedrani R
    Drug Metab Dispos; 2008 Aug; 36(8):1457-60. PubMed ID: 18448571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of everolimus metabolite patterns in trough blood samples of kidney transplant patients.
    Strom T; Haschke M; Zhang YL; Bendrick-Peart J; Boyd J; Roberts M; Arabshahi L; Marbach P; Christians U
    Ther Drug Monit; 2007 Oct; 29(5):592-9. PubMed ID: 17898649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation from pig liver microsomes, identification by tandem mass spectrometry and in vitro immunosuppressive activity of an SDZ-RAD 17,18,19,20,21,22-tris-epoxide.
    Lhoëst GJ; Gougnard TY; Verbeeck RK; Maton N; Dehoux JP; Wallemacq P; Schüler W; Latinne D
    J Mass Spectrom; 2000 Mar; 35(3):454-60. PubMed ID: 10767777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crossreactivity of isolated everolimus metabolites with the Innofluor Certican immunoassay for therapeutic drug monitoring of everolimus.
    Strom T; Haschke M; Boyd J; Roberts M; Arabshahi L; Marbach P; Christians U
    Ther Drug Monit; 2007 Dec; 29(6):743-9. PubMed ID: 18043471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro immunosuppressive activity of tacrolimus dihydrodiol precursors obtained by chemical oxidation and identification of a new metabolite of SDZ-RAD by electrospray and electrospray-linked scan mass spectrometry.
    Lhoëst G; Hertsens R; Verbeeck RK; Maton N; Wallemacq P; Dehoux JP; Latinne D
    J Mass Spectrom; 2001 Aug; 36(8):889-901. PubMed ID: 11523088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Further metabolism of FK506 (tacrolimus). Identification and biological activities of the metabolites oxidized at multiple sites of FK506.
    Iwasaki K; Shiraga T; Matsuda H; Nagase K; Tokuma Y; Hata T; Fujii Y; Sakuma S; Fujitsu T; Fujikawa A
    Drug Metab Dispos; 1995 Jan; 23(1):28-34. PubMed ID: 7536652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro immunosuppressive activity, isolation from pig liver microsomes and identification by electrospray ms-ms of a new FK-506 C19-C20 epoxide metabolite.
    Lhoëst G; Dieden R; Verbeeck RK; Maton N; Ingendoh A; Latinne D
    J Pharmacol Exp Ther; 1998 Mar; 284(3):1074-81. PubMed ID: 9495869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation, identification, and biological activities of oxidative metabolites of FK506, a potent immunosuppressive macrolide lactone.
    Iwasaki K; Shiraga T; Nagase K; Tozuka Z; Noda K; Sakuma S; Fujitsu T; Shimatani K; Sato A; Fujioka M
    Drug Metab Dispos; 1993; 21(6):971-7. PubMed ID: 7507815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural elucidation by electrospray mass spectrometry: an approach to the in vitro metabolism of the macrolide immunosuppressant SDZ RAD.
    Vidal C; Kirchner GI; Sewing KF
    J Am Soc Mass Spectrom; 1998 Dec; 9(12):1267-74. PubMed ID: 9835072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Robust, high-throughput LC-MS/MS method for therapeutic drug monitoring of cyclosporine, tacrolimus, everolimus, and sirolimus in whole blood.
    Koster RA; Dijkers EC; Uges DR
    Ther Drug Monit; 2009 Feb; 31(1):116-25. PubMed ID: 19065123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laryngeal transplantation in the setting of cancer: a rat model.
    Shipchandler TZ; Lorenz RR; Lee WT; Teker AM; Dan O; Strome M
    Laryngoscope; 2008 Dec; 118(12):2166-71. PubMed ID: 18948827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Internal standard selection for the high-performance liquid chromatography tandem mass spectroscopy assay of everolimus in blood.
    Hoogtanders K; van der Heijden J; Stolk LM; Neef C; Christiaans M; van Hooff J
    Ther Drug Monit; 2007 Oct; 29(5):673-4. PubMed ID: 17898665
    [No Abstract]   [Full Text] [Related]  

  • 13. Identification of a new metabolite of macrolide immunosuppressant, like rapamycin and SDZ RAD, using high performance liquid chromatography and electrospray tandem mass spectrometry.
    Hallensleben K; Raida M; Habermehl G
    J Am Soc Mass Spectrom; 2000 Jun; 11(6):516-25. PubMed ID: 10833025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Everolimus alters imatinib blood partition in favour of the erythrocyte.
    Prenen H; Guetens G; De Boeck G; Highley M; van Oosterom AT; de Bruijn EA
    J Pharm Pharmacol; 2006 Aug; 58(8):1063-6. PubMed ID: 16872552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Everolimus and sirolimus antagonize tacrolimus based calcineurin inhibition via competition for FK-binding protein 12.
    van Rossum HH; Romijn FP; Smit NP; de Fijter JW; van Pelt J
    Biochem Pharmacol; 2009 Apr; 77(7):1206-12. PubMed ID: 19154728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of everolimus as an antiproliferative agent on regression of encapsulating peritoneal sclerosis in a rat model.
    Duman S; Bozkurt D; Sipahi S; Sezak M; Ozkan S; Ertilav M; Sen S; Ok E
    Adv Perit Dial; 2008; 24():104-10. PubMed ID: 18986012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic exposure of everolimus after stent implantation: a pharmacokinetic study.
    Wiemer M; Seth A; Chandra P; Neuzner J; Richardt G; Piek JJ; Desaga M; Macaya C; Bol CJ; Miquel-Hebert K; De Roeck K; Serruys PW
    Am Heart J; 2008 Oct; 156(4):751.e1-7. PubMed ID: 18926156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the in vitro metabolism of the macrolide immunosuppressants sirolimus and RAD.
    Jacobsen W; Serkova N; Hausen B; Morris RE; Benet LZ; Christians U
    Transplant Proc; 2001; 33(1-2):514-5. PubMed ID: 11266932
    [No Abstract]   [Full Text] [Related]  

  • 19. Everolimus inhibits monocyte/macrophage migration in vitro and their accumulation in carotid lesions of cholesterol-fed rabbits.
    Baetta R; Granata A; Canavesi M; Ferri N; Arnaboldi L; Bellosta S; Pfister P; Corsini A
    J Pharmacol Exp Ther; 2009 Feb; 328(2):419-25. PubMed ID: 19023042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism, pharmacokinetics, and excretion of a cholesteryl ester transfer protein inhibitor, torcetrapib, in rats, monkeys, and mice: characterization of unusual and novel metabolites by high-resolution liquid chromatography-tandem mass spectrometry and 1H nuclear magnetic resonance.
    Prakash C; Chen W; Rossulek M; Johnson K; Zhang C; O'Connell T; Potchoiba M; Dalvie D
    Drug Metab Dispos; 2008 Oct; 36(10):2064-79. PubMed ID: 18653742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.